Substance / Medication

Medium chain triglycerides

Overview

Active Ingredient
medium chain triglycerides
RxNorm CUI
1310578

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

87 trials linked to this intervention

87
Total Trials
19
Recruiting
31
With Results

Research Evidence

Published studies and systematic reviews

Sort:
AMPA Receptor Modulation Through Medium-Chain Triglycerides and Decanoic Acid Supports Nutritional Intervention in Pediatric Epilepsy.
Falsaperla Raffaele, Sortino Vincenzo, Soler Miguel Angel et al. · Nutrients · 2025
PMID: 40507074Meta-AnalysisFull text (PMC)
Medium-chain triglycerides may improve memory in non-demented older adults: a systematic review of randomized controlled trials.
Giannos Panagiotis, Prokopidis Konstantinos, Lidoriki Irene et al. · BMC Geriatr · 2022
PMID: 36273115Meta-AnalysisFull text (PMC)
A systematic review and meta-analysis of medium-chain triglycerides effects on acute satiety and food intake.
Maher Tyler, Clegg Miriam E · Crit Rev Food Sci Nutr · 2021
PMID: 32212947Meta-Analysis
Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies.
Avgerinos Konstantinos I, Egan Josephine M, Mattson Mark P et al. · Ageing Res Rev · 2020
PMID: 31870908Meta-AnalysisFull text (PMC)
Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials.
Mumme Karen, Stonehouse Welma · J Acad Nutr Diet · 2015
PMID: 25636220Meta-Analysis
Influence of medium-chain triglycerides on consumption and weight gain in rats: a systematic review.
Ferreira L, Lisenko K, Barros B et al. · J Anim Physiol Anim Nutr (Berl) · 2014
PMID: 23298149Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Medium chain triglyceride (substance)
SNOMED CT
395781005
UMLS CUI
C0724624
RxNorm CUI
1310578

Clinical Data

This intervention maps to 18 entities in the Ltrl knowledge graph.

7
Conditions
4
Biomarkers
4
Specialists
0
Symptoms
87
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Medium chain triglycerides: Uses, Evidence & Side Effects | Ltrl